Remove Biopharma Remove Competition Remove Physicians Remove Prospecting
article thumbnail

HCP Engagement & Education

PM360

From important changes to engaging physicians to finding out how new technologies will help address HCPs education needs, hear what our specialist had to say. What do you think are the most important changes to engaging physicians our industry needs to keep in mind now?

article thumbnail

Why Sales Representatives Should Deviate from Call Plans

The Marketing Advantage

July 10, 2023 One of the functions most critical to maximizing the productivity and efficiency of the sales force’s efforts is call planning —how often a physician target should be seen by a sales representative. In fact, in one case, the prescriber was the spouse of a competitive sales representative.

Sales 40
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Five IDNs to watch in 2023

Clarivate

In a fiercely competitive U.S. While marquee IDNs attract national headlines, these smaller systems reflect how markets are adjusting to an increasingly value-based and competitive landscape. ChristianaCare’s future expansion plans could escalate the competition between Highmark and UPMC. ChristianaCare, Wilmington, Delaware.

article thumbnail

Top oncology breakthroughs shared at ESMO 2021

Clarivate

Competition is imminent as the CheckMate-76K trial evaluating Bristol-Myers Squibb’s Opdivo in stage IIB-C melanoma patients is also poised to enter this setting. Kisqali plus letrozole demonstrated a significant OS benefit, but is that enough to displace physician favorite Ibrance? Kisqali in the battle of the CDK4/6 inhibitors 3.